A. Gajjar et al., Comparison of lumbar and shunt cerebrospinal fluid specimens for cytologicdetection of leptomeningeal disease in pediatric patients with brain tumors, J CL ONCOL, 17(6), 1999, pp. 1825-1828
Purpose: Leptomeningeal disease (LMD) significantly affects the prognosis a
nd treatment of pediatric patients with primary CNS tumors. Cytologic exami
nation of lumbar CSF is routinely used to detect LMD. To determine whether
examination of CSF obtained from ventricular shunt taps is a more sensitive
method of detecting LMD in these patients, we designed a prospective study
to compare the findings of cytologic examinations of CSF obtained from con
current lumbar and ventriculoperitoneal (VP) shunt taps.
Patients and Methods: As a parr of diagnostic staging, follow-up testing, o
r both, 52 consecutive patients underwent concurrent lumbar and shunt taps
on 90 separate occasions, ranging from the time of diagnosis to treatment f
ollow-up. CSF from both sites was examined cytologically for malignant cell
s.
Results: The median age of the 28 males and 24 females was 7.5 years (range
, 0.6 to 21.4 years). The primary CNS tumors included medulloblastoma. (n =
29), astrocytoma (n = 10),ependymoma(n = 5), germinoma (n = 3), atypical t
eratoid rhabdoid tumor (n = 2), choroid plexus carcinoma (n = 2), and pineo
blastoma (n = 1). Each site yielded a median CSF volume of 1.0 mt. Fourteen
of 90 paired CSF test results were discordant: in 12, the cytologic findin
gs from shunt CSF were negative for malignant cells, but those from lumbar
CSF were positive; in two, the reverse was true. Malignant cells were detec
ted at a higher rate in lumbar CSF than in shunt CSF (P = .0018). When repe
at analyses were excluded, examination of lumbar CSF remained significantly
more sensitive in detecting malignant cells (P = .011). Analysis of the su
bset of patients with embryonal tumors showed similar results (P = .0008).
Conclusion: Cytologic examination of lumbar CSF is clearly superior to cyto
logic examination of: VP shunt CSF for detecting leptomeningeal metastases
in pediatric patients with primary CNS tumors.
(C) 1999 by American Society of Clinical Oncology.